Name: Latest research reports of Supriya Lifescience Ltd. authored by KRChoksey and published by - Trendlyne research reports.
Item: Supriya Lifescience Ltd.
Rating: 4
Author: KRChoksey

Solid revenue growth driven by volume increase

Accumulate: Supriya Lifescience Ltd.

Recommendation Target

KRChoksey

For Q2FY24, Supriya Lifescience's revenue grew 24.9% YoY and 6.1% QoQ to INR 1,401 Mn, while for H1FY24, revenue grew 27.4% YoY to 2,721 Mn. In terms of revenue break up, analgesic/anti-pyretic/anesthetic (56.0% share in Q2FY24) grew by 29.9% YoY, anti histamine (2.0% share in Q2FY24) grew by 21.8% YoY, vitamin (11.0% share in Q2FY24) grew by 26.3% YoY, anti-asthma (10.0% share in Q2FY24) grew by 26.2% YoY, anti-allergic (8.0% share in Q2FY24) grew by 31.9% YoY, anti-malarial (2.0% share in Q2FY24) grew by 3.8% YoY, and others (11.0% share in Q2FY24) grew by 3.4% YoY.